BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 38645367)

  • 1. Future treatments for hepatitis delta virus infection.
    Asselah T; Loureiro D; Tout I; Castelnau C; Boyer N; Marcellin P; Mansouri A
    Liver Int; 2020 Feb; 40 Suppl 1():54-60. PubMed ID: 32077603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis delta virus diagnosis.
    Olivero A; Smedile A
    Semin Liver Dis; 2012 Aug; 32(3):220-7. PubMed ID: 22932970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving Access to Anti-HDV Testing: Development and Validation of an Affordable In-House ELISA Assay.
    Amin I; Rafique S; Ali A; Ahmed N; Shahid M; Afzal S; Tahir S; Waqas M; Bibi S; Elgorban AM; Idrees M; Shah M; Syed A
    ACS Omega; 2024 Apr; 9(15):17137-17142. PubMed ID: 38645367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of commercial enzyme immunoassays for detection of hepatitis delta antigen and anti-hepatitis delta virus (HDV) and immunoglobulin M anti-HDV antibodies.
    Shattock AG; Morris MC
    J Clin Microbiol; 1991 Sep; 29(9):1873-6. PubMed ID: 1774310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a hepatitis delta virus antibody assay for study of the prevalence of HDV among individuals infected with hepatitis B virus in China.
    Shen L; Gu Y; Sun L; Yang Y; Wang F; Li Y; Bi S
    J Med Virol; 2012 Mar; 84(3):445-9. PubMed ID: 22246830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to synthetic peptides of hepatitis delta antigen.
    Poisson F; Baillou F; Dubois F; Janvier B; Roingeard P; Goudeau A
    J Clin Microbiol; 1993 Sep; 31(9):2343-9. PubMed ID: 8408553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers.
    Pol S; Wesenfelder L; Dubois F; Roingeard P; Carnot F; Driss F; Brechot C; Goudeau A; Berthelot P
    J Viral Hepat; 1994; 1(2):131-7. PubMed ID: 8790568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan.
    Lin GY; Wu YL; Wang CS; Ko CY; Chen CH; Chen PJ; Peng PH; Hsu CW
    Virol J; 2020 Jun; 17(1):76. PubMed ID: 32546164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review of HDV Infection.
    Caviglia GP; Ciancio A; Rizzetto M
    Viruses; 2022 Aug; 14(8):. PubMed ID: 36016371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis D: challenges in the estimation of true prevalence and laboratory diagnosis.
    Chen LY; Pang XY; Goyal H; Yang RX; Xu HG
    Gut Pathog; 2021 Oct; 13(1):66. PubMed ID: 34717740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?
    Hayashi T; Takeshita Y; Hutin YJ; Harmanci H; Easterbrook P; Hess S; van Holten J; Oru EO; Kaneko S; Yurdaydin C; Bulterys M
    Arch Public Health; 2021 Oct; 79(1):180. PubMed ID: 34663473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing context of hepatitis D.
    Rizzetto M; Hamid S; Negro F
    J Hepatol; 2021 May; 74(5):1200-1211. PubMed ID: 33484770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis.
    Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM
    J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the Global Prevalence, Disease Progression, and Clinical Outcome of Hepatitis Delta Virus Infection.
    Miao Z; Zhang S; Ou X; Li S; Ma Z; Wang W; Peppelenbosch MP; Liu J; Pan Q
    J Infect Dis; 2020 Apr; 221(10):1677-1687. PubMed ID: 31778167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Hepatitis Delta Virus Among Pregnant Women of Pakistan.
    Aftab M; Naz S; Aftab B; Ali A; Rafique S; Fatima Z; Inamullah ; Idrees M
    Viral Immunol; 2019 Oct; 32(8):335-340. PubMed ID: 31553269
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.